These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 15296587)

  • 1. Transfer of naltrexone and its metabolite 6,beta-naltrexol into human milk.
    Chan CF; Page-Sharp M; Kristensen JH; O'Neil G; Ilett KF
    J Hum Lact; 2004 Aug; 20(3):322-6. PubMed ID: 15296587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum 6-beta-naltrexol levels are related to alcohol responses in heavy drinkers.
    McCaul ME; Wand GS; Rohde C; Lee SM
    Alcohol Clin Exp Res; 2000 Sep; 24(9):1385-91. PubMed ID: 11003204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single- and multiple-dose pharmacokinetics of long-acting injectable naltrexone.
    Dunbar JL; Turncliff RZ; Dong Q; Silverman BL; Ehrich EW; Lasseter KC
    Alcohol Clin Exp Res; 2006 Mar; 30(3):480-90. PubMed ID: 16499489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of naltrexone and 6,beta-naltrexol in plasma and milk using gas chromatography-mass spectrometry. Application to studies in the lactating sheep.
    Chan CF; Chiswell GM; Bencini R; Hackett LP; Dusci LJ; Ilett KF
    J Chromatogr B Biomed Sci Appl; 2001 Sep; 761(1):85-92. PubMed ID: 11585135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum naltrexone and 6-beta-naltrexol levels from naltrexone implants can block very large amounts of heroin: a report of two cases.
    Brewer C
    Addict Biol; 2002 Jul; 7(3):321-3. PubMed ID: 12126492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determination of naltrexone and 6-beta-naltrexol in human plasma following implantation of naltrexone pellets using gas chromatography-mass spectrometry.
    Toennes SW; Kauert GF; Grüsser SM; Jäkel W; Partecke G
    J Pharm Biomed Anal; 2004 Apr; 35(1):169-76. PubMed ID: 15030891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 6-beta-naltrexol reduces alcohol consumption in rats.
    Rukstalis MR; Stromberg MF; O'Brien CP; Volpicelli JR
    Alcohol Clin Exp Res; 2000 Oct; 24(10):1593-6. PubMed ID: 11045869
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioequivalence, dose-proportionality, and pharmacokinetics of naltrexone after oral administration.
    Meyer MC; Straughn AB; Lo MW; Schary WL; Whitney CC
    J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):15-9. PubMed ID: 6469932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naltrexone biotransformation and incidence of subjective side effects: a preliminary study.
    King AC; Volpicelli JR; Gunduz M; O'Brien CP; Kreek MJ
    Alcohol Clin Exp Res; 1997 Aug; 21(5):906-9. PubMed ID: 9267542
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolism and disposition of naltrexone in man after oral and intravenous administration.
    Wall ME; Brine DR; Perez-Reyes M
    Drug Metab Dispos; 1981; 9(4):369-75. PubMed ID: 6114837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ex vivo studies for the passive transdermal delivery of low-dose naltrexone from a cream; detection of naltrexone and its active metabolite, 6β-naltrexol, using a novel LC Q-ToF MS assay.
    Dodou K; Armstrong A; Kelly I; Wilkinson S; Carr K; Shattock P; Whiteley P
    Pharm Dev Technol; 2015; 20(6):694-701. PubMed ID: 24785567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of infant dose through milk in a lactating woman taking amisulpride and desvenlafaxine for treatment-resistant depression.
    Ilett KF; Watt F; Hackett LP; Kohan R; Teoh S
    Ther Drug Monit; 2010 Dec; 32(6):704-7. PubMed ID: 20926994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The urinary excretion profiles of naltrexone in man, monkey, rabbit, and rat.
    Dayton HE; Inturrisi CE
    Drug Metab Dispos; 1976; 4(5):474-8. PubMed ID: 10147
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Achieving long-term continuous blood naltrexone and 6-beta-naltrexol coverage following sequential naltrexone implants.
    Hulse GK; Arnold-Reed DE; O'Neil G; Chan CT; Hansson RC
    Addict Biol; 2004 Mar; 9(1):67-72. PubMed ID: 15203441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics of long-acting naltrexone in subjects with mild to moderate hepatic impairment.
    Turncliff RZ; Dunbar JL; Dong Q; Silverman BL; Ehrich EW; Dilzer SC; Lasseter KC
    J Clin Pharmacol; 2005 Nov; 45(11):1259-67. PubMed ID: 16239359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of liver cirrhosis on the systemic availability of naltrexone in humans.
    Bertolotti M; Ferrari A; Vitale G; Stefani M; Trenti T; Loria P; Carubbi F; Carulli N; Sternieri E
    J Hepatol; 1997 Sep; 27(3):505-11. PubMed ID: 9314128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determination of naltrexone and 6-beta-naltrexol in plasma by solid-phase extraction and gas chromatography-negative ion chemical ionization-mass spectrometry.
    Huang W; Moody DE; Foltz RL; Walsh SL
    J Anal Toxicol; 1997; 21(4):252-7. PubMed ID: 9248940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transfer of buprenorphine into breast milk and calculation of infant drug dose.
    Lindemalm S; Nydert P; Svensson JO; Stahle L; Sarman I
    J Hum Lact; 2009 May; 25(2):199-205. PubMed ID: 19136395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transfer of metformin into human milk.
    Hale TW; Kristensen JH; Hackett LP; Kohan R; Ilett KF
    Diabetologia; 2002 Nov; 45(11):1509-14. PubMed ID: 12436333
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of a liquid chromatography-mass spectrometry method for the quantitation of naltrexone and 6beta-naltrexol in guinea pig plasma.
    Valiveti S; Nalluri BN; Hammell DC; Paudel KS; Stinchcomb AL
    J Chromatogr B Analyt Technol Biomed Life Sci; 2004 Oct; 810(2):259-67. PubMed ID: 15380723
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.